Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years

Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years

ObjectivesTo assess antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged 50 and older.MethodsWe conducted a post-market cross-sectional seroepidemiology study. We recruited 4,632 vaccinated individuals aged 50 and older, measured their total serum SARS-CoV-2-specific antibody...

Full description

Bibliographic Details
Main Authors: Hong-Hong Zhu, Guo-Qing Sun, Ji-Yu Wu, Su-Qing Fan, Ying-Ying Zhu, Zhi-Cheng Wang, Xiao-Fang Liao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Immunology
Subjects:
inactivated SARS-CoV-2 vaccine
antibody
seroepidemiology
phase 4 trial
chronic disease
hypertension
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1212988/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1212988/full

Similar Items